Pharma & Biotech Market Research
In this section you will find information products, including market research reports, on the following sector: Pharma & Biotech
Stay up-to-date with new products added to this category
previous
Title  | Date  | Price |
|---|---|---|
| Novo Nordisk A/S - SWOT Analysis | Jun 2008 | £63 |
| Elan Corporation, plc - SWOT Analysis | Jun 2008 | £63 |
| Johnson & Johnson - SWOT Analysis | Jun 2008 | £63 |
| W. R. Grace & Co - SWOT Analysis | Jun 2008 | £63 |
| Sigma-Aldrich Corporation - SWOT Analysis | Jun 2008 | £63 |
| Wyeth - SWOT Analysis | Jun 2008 | £63 |
| Menarini Group - SWOT Analysis | Jun 2008 | £63 |
| Transammonia, Inc. - SWOT Analysis | Jun 2008 | £63 |
| CVS Caremark Corporation - SWOT Analysis | Jun 2008 | £63 |
| H Lundbeck A/S - SWOT Analysis | Jun 2008 | £63 |
| Nycomed International Management GmbH - SWOT Analysis | Jun 2008 | £63 |
| PolyOne Corporation - SWOT Analysis | Jun 2008 | £63 |
| Chemtura Corporation - SWOT Analysis | Jun 2008 | £63 |
| Boehringer Ingelheim GmbH - SWOT Analysis | Jun 2008 | £63 |
| King Pharmaceuticals, Inc - SWOT Analysis | Jun 2008 | £63 |
| Allergan, Inc. - SWOT Analysis | Jun 2008 | £63 |
| E.ON AG - SWOT Analysis | Jun 2008 | £63 |
| UCB Group - SWOT Analysis | Jun 2008 | £63 |
| Forest Laboratories, Inc - SWOT Analysis | Jun 2008 | £63 |
| Endo Pharmaceuticals Holdings Inc. - SWOT Analysis | Jun 2008 | £63 |
| UnitedHealth Group Inc. - SWOT Analysis | Jun 2008 | £63 |
| Les Laboratoires Servier - SWOT Analysis | Jun 2008 | £63 |
| Sepracor Inc. - SWOT Analysis | Jun 2008 | £63 |
| Bard Medical Device Company Intelligence Report | May 2008 | £295 |
| Kinetic Concepts Medical Device Company Intelligence Report | May 2008 | £395 |
| Larka CMO Companies Listing Online Directory | May 2008 | £435 |
| Lev Pharmaceuticals Inc Premium Company Profile | Apr 2008 | £265 |
| Allos Therapeutics Inc Premium Company Profile | Apr 2008 | £265 |
| Antisoma plc Premium Company Profile | Apr 2008 | £265 |
| Beckman Coulter Inc Premium Company Profile | Apr 2008 | £265 |
| Bioms Medical Corp Premium Company Profile | Apr 2008 | £265 |
| Anesiva Inc Premium Company Profile | Apr 2008 | £265 |
| Boston Scientific Corporation Premium Company Profile | Apr 2008 | £265 |
| Carl Zeiss Meditec Ag Premium Company Profile | Apr 2008 | £265 |
| Zimmer Holdings Inc Premium Company Profile | Apr 2008 | £265 |
| Varian Medical Systems Inc Premium Company Profile | Apr 2008 | £265 |
| Csl Limited Premium Company Profile | Apr 2008 | £265 |
| Micromet Inc Premium Company Profile | Apr 2008 | £265 |
| Optimer Pharmaceuticals Inc Premium Company Profile | Apr 2008 | £265 |
| Javelin Pharmaceuticals Inc Premium Company Profile | Apr 2008 | £265 |
| Spectrum Pharmaceuticals Inc Premium Company Profile | Apr 2008 | £265 |
| Nuvelo Inc Premium Company Profile | Apr 2008 | £265 |
| Incyte Corporation Premium Company Profile | Apr 2008 | £265 |
| Stryker Corporation Premium Company Profile | Apr 2008 | £265 |
| Panacos Pharmaceuticals Inc Premium Company Profile | Apr 2008 | £265 |
| La Jolla Pharmaceutical Co Premium Company Profile | Apr 2008 | £265 |
| Lexicon Pharmaceuticals Inc Premium Company Profile | Apr 2008 | £265 |
| Kv Pharmaceutical Company Premium Company Profile | Apr 2008 | £265 |
| Avigen Inc Premium Company Profile | Apr 2008 | £265 |
| C.R. Bard Inc Premium Company Profile | Apr 2008 | £265 |
| Danaher Corporation Premium Company Profile | Apr 2008 | £265 |
| Medtronic Inc Premium Company Profile | Apr 2008 | £265 |
| Smith & Nephew plc Premium Company Profile | Apr 2008 | £265 |
| Transition Therapeutics Inc Premium Company Profile | Apr 2008 | £265 |
| TorreyPines Therapeutics Inc Premium Company Profile | Apr 2008 | £265 |
| St. Jude Medical Inc Premium Company Profile | Apr 2008 | £265 |
| Novacea Inc Premium Company Profile | Apr 2008 | £265 |
| Illumina Inc Premium Company Profile | Apr 2008 | £265 |
| LifeCell Corporation Premium Company Profile | Apr 2008 | £265 |
| MannKind Corporation Premium Company Profile | Apr 2008 | £265 |
| Cytori Therapeutics Inc Premium Company Profile | Apr 2008 | £265 |
| Cougar Biotechnology Inc Premium Company Profile | Apr 2008 | £265 |
| MorphoSys Ag Premium Company Profile | Apr 2008 | £265 |
| Introgen Therapeutics Inc Premium Company Profile | Apr 2008 | £265 |
| Theratechnologies Inc Premium Company Profile | Apr 2008 | £265 |
| Poniard Pharmaceuticals Inc Premium Company Profile | Apr 2008 | £265 |
| Becton, Dickinson and Co Premium Company Profile | Apr 2008 | £265 |
| Cadinal Health Medical Device Company Intelligence Report | Apr 2008 | £395 |
| Hill-Rom Medical Device Company Intelligence Report | Apr 2008 | £395 |
| Cytogen Corporation SWOT Analysis | Apr 2008 | £63 |
| Collagenex Pharmaceuticals, Inc. SWOT Analysis | Apr 2008 | £63 |
| Santarus, Inc. SWOT Analysis | Apr 2008 | £63 |
| Nastech Pharmaceutical Company Inc SWOT Analysis | Apr 2008 | £63 |
| Cardinal Health, Inc. SWOT Analysis | Apr 2008 | £63 |
| Pfizer Inc SWOT Analysis | Apr 2008 | £63 |
| Biogen Idec, Inc. SWOT Analysis | Apr 2008 | £63 |
| Shire Plc SWOT Analysis | Apr 2008 | £63 |
| Amgen Inc. SWOT Analysis | Apr 2008 | £63 |
| International Directory of Pharmaceutical Companies 2008 | Apr 2008 | £505 |
| Introduction of 101 China-based CROs/CMOs serving Western Pharmaceutical and Biotechnology Industry | Apr 2008 | £460 |
| Hospira Generics Company Intelligence Report | Mar 2008 | £195 |
| Biogen Idec Pipeline Products Performance Potential | Mar 2008 | £595 |
| Chugai Pipeline Products Performance Potential | Mar 2008 | £595 |
| Chuga Pipeline Products Performance Potential | Mar 2008 | £1,220 |
| Lannett Generics Company Intelligence Report | Mar 2008 | £195 |
| Gedeon Richter Generics Company Intelligence Report | Mar 2008 | £195 |
| Egis Generics Company Intelligence Report | Mar 2008 | £195 |
| Wockhardt Generics Company Intelligence Report | Mar 2008 | £195 |
| Zentiva Generics Company Intelligence Report | Mar 2008 | £195 |
| Zydus Cadila Generics Company Intelligence Report | Mar 2008 | £195 |
| Aspen Pharmacare Generics Company Intelligence Report | Mar 2008 | £195 |
| Apotex Generics Company Intelligence Report | Mar 2008 | £195 |
| Actavis Generics Company Intelligence Report | Mar 2008 | £195 |
| Dr Reddy's Laboratories Generics Company Intelligence Report | Mar 2008 | £195 |
| Cipla Generics Company Intelligence Report | Mar 2008 | £195 |
| Barr Pharmaceuticals Generics Company Intelligence Report | Mar 2008 | £195 |
| Perrigo Generics Company Intelligence Report | Mar 2008 | £195 |
| Pliva Generics Company Intelligence Report | Mar 2008 | £195 |
| Ranbaxy Generics Company Intelligence Report | Mar 2008 | £195 |
| Krka Generics Company Intelligence Report | Mar 2008 | £195 |
